Clinical Trials Logo

Filter by:
NCT ID: NCT03061136 Withdrawn - Schizophrenia Clinical Trials

Clonazepam Effects on Brain Oscillations and Cognition in Schizophrenia

KGB
Start date: October 2016
Phase: Phase 4
Study type: Interventional

Cognitive deficits are some of the most prominent and disabling symptoms of schizophrenia. Evidence suggests that schizophrenia involves alterations to the functioning of a neural system under the control of a brain chemical called GABA. The present project will compare the effects of low-dose clonazepam (at a sub-sedating dose) to placebo, for effects on GABA- modulated brain activity measured by EEG, and associated cognitive processes in people who have schizophrenia.

NCT ID: NCT03061110 Withdrawn - Clinical trials for Xerostomia Due to Radiotherapy (Disorder)

Stromal Vascular Fraction for Treatment of Xerostomia

Start date: November 1, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

Prospective, single center, double armed, randomized treatment with observation only (standard of care) control group. Subjects receiving study treatment will have 6 months of study follow-up. Stromal vascular fraction (SVF), an adipose-derived tissue preparation, will be injected into salivary glands to determine safety and efficacy to restore saliva production in head and neck cancer patients with chronic xerostomia resulting from radiation therapy.

NCT ID: NCT03059277 Withdrawn - Clinical trials for Diabetic Macular Edema

Intravitreal Alfibercept for Center Involved DME Previously Managed With Intravitreal Ranibizumab

Start date: June 1, 2018
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine the efficacy of intravitreal aflibercept injections administered in a treat and extend fashion in eyes that have persistent center involved diabetic macular edema following at least 4 intravitreal injections of 0.3 mg ranibizumab over 24 weeks.

NCT ID: NCT03057990 Withdrawn - Clinical trials for Myelodysplastic Syndromes

Pyrimethamine for Intermediate/High-risk Myelodysplastic Syndromes (MDS)

Start date: September 11, 2019
Phase: Phase 1
Study type: Interventional

This is a phase I study designed to assess the maximum tolerated dose (MTD) of pyrimethamine and provide the recommended Phase 2 dose (RP2D) for the treatment of intermediate/high-risk MDS that is refractory to or relapsed after treatment with azanucleosides.

NCT ID: NCT03057678 Withdrawn - Acoustic Neuroma Clinical Trials

Evaluating the Pre-Positioning Frame for Robotic Acoustic Neuroma Removal Surgery

PPF
Start date: December 2021
Phase: N/A
Study type: Interventional

Otologic surgery often involves a mastoidectomy to safely access the inner ear. In this procedure, a portion of the mastoid part of the temporal bone is removed. The surgery is lengthy and challenging because many critical structures are embedded in the mastoid and are difficult to identify and accurately remove with a surgical drill. In previous work, the investigators developed a compact, bone-attached robot to automate mastoidectomy drilling for translabyrinthine acoustic neuroma removal (TANR). The robot does not attach directly to the bone. Instead, a rigid surgical fixture which the investigators call a prepositioning frame (PPF) is attached to the temporal bone, and the robot attaches to the PPF. Attaching the robot to the participant eliminates the need for an expensive image guidance system to compensate for participant motion, but requires a compact robot with a limited range of motion. The PPF supports the robot on the head such that a planned mastoidectomy volume is within the robot's range of motion. In this study, the investigators plan to test the PPF by attaching it to ten participants. By processing an intraoperative CT scan of the attached PPF, the investigators will measure the percentage of each planned mastoidectomy that would be reachable if the robot were attached. The investigators will also measure the time required to attach the PPF. The data the investigators acquire will enable further improvements to the PPF design, which would be advantageous before proceeding to robotic drilling experiments.

NCT ID: NCT03057587 Withdrawn - Blood Pressure Clinical Trials

The Newborn Project: Examining the Oxygenation of Brain Tissue During General Anesthesia

Start date: May 12, 2017
Phase:
Study type: Observational

This study will be an observational, prospective trial that will measure the cerebral oxygenation of infants scheduled to undergo general anesthesia at Boston Children's Hospital.

NCT ID: NCT03057509 Withdrawn - Clinical trials for Small Bowel Carcinoid Tumor

A Pilot Study Of Ga-68-DOTA-TOC Imaging In Participants With Small Bowel Carcinoid Tumors

Start date: November 2018
Phase: Phase 1
Study type: Interventional

This research study is designed to evaluate a type of scan called Ga-68-DOTA-TOC positron emission tomography (PET) scanning as a way of assessing carcinoid tumors.

NCT ID: NCT03056378 Withdrawn - Anemia Clinical Trials

POOLED Red Blood Cells Prepared From Pooling 5 Leukoreduced, Irradiated RBC Units

Pooled RBCs
Start date: October 2019
Phase: Phase 1
Study type: Interventional

The purpose of the study is to determine the safety of pooled red blood cells (RBCs) compared to standard leukoreduced RBC products stored in additive solution. The primary objective is to determine if there is no significant difference in transfusion associated adverse events in POOLED-RBCs compared to standard RBC product groups. Secondarily to determine if there are no significant differences in new antibody and new positive direct antiglobulin test (DAT) formation in the POOLED-RBCs compared to standard RBC product groups.

NCT ID: NCT03055884 Withdrawn - Healthy Adults Clinical Trials

Investigating Accelerated Learning in Healthy Subjects

Start date: February 13, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate whether it is possible to accelerate learning and improve associative memory performance in healthy subjects, by (1) applying transcranial Direct Current Stimulation (tDCS) during a verbal paired-associate learning task and by (2) optimizing the learning method with repeated retrieval practice.

NCT ID: NCT03054948 Withdrawn - Clinical trials for Short Bowel Syndrome

SMOFLipid in Patients Who Are Intralipid Intolerant

Start date: February 1, 2017
Phase: Phase 4
Study type: Interventional

Soybean oil based IV fat emulsion (IVFE) has been one of the sole sources of IVFE in the US. Soybean oil based IVFE has higher ratio of omega-6 to omega-3 fatty acids and can be associated with a number of complications including inflammation, abnormal liver function tests (reflecting steatosis, cholestasis, etc.), and metabolic abnormalities. Recently the FDA has approved SMOFlipid which contains a mixture of soybean oil, medium chain triglycerides, olive oil, and fish oil. It provides a more positive ratio of omega-3 to omega-6 fatty acids and has been shown in short term trials to be beneficial in cases of intolerance to soybean oil IVFE. This study is designed to investigate the impact of SMOFlipid in prolonged use.